James Frederick is a practicing Physician Associate (PA-C, MMSc) who studied at Yale University. He also has a bachelor’s degree in creative writing and English Literature from the University of Colorado. He specializes in writing medical content that is approachable, readable and enjoyable. He has a strong background in research, physiology, pharmacotherapy, emergency medicine and critical care medicine. In his free time, he enjoys spending time camping and traveling with his wife and dog.
The first-in-human clinical trial assessing the safety and tolerability of Miltuximab (MIL-38) — a radiolabeled antibody designed to image prostate, bladder, and pancreatic cancer — is proceeding to its second part, ... Read more
British researchers have developed what they call a three-in-one blood test for advanced prostate cancer — one that helps doctors select an initial treatment, check whether it is working, ... Read more
Men with localized prostate cancer may want to consider active surveillance over surgery or radiation therapy, suggests a study by Tennessee’s Vanderbilt University Medical Center . The study, “Association Between ... Read more
Pin It on Pinterest